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Abstract
Background: Expatriates are a distinct population at unique risk for health problems related to their travel
exposure.
Methods: We analyzed GeoSentinel data comparing ill returned expatriates with other travelers for demographics,
travel characteristics, and proportionate morbidity (PM) for travel-related illness.
Results: Our study included 2,883 expatriates and 11,910 non-expatriates who visited GeoSentinel clinics ill after
travel. Expatriates were more likely to be male, do volunteer work, be long-stay travelers (>6 months), and have
sought pre-travel advice. Compared to non-expatriates, expatriates returning from Africa had higher proportionate
morbidity (PM) for malaria, filariasis, schistosomiasis, and hepatitis E; expatriates from the Asia-Pacific region had
higher PM for strongyloidiasis, depression, and anxiety; expatriates returning from Latin America had higher PM for
mononucleosis and ingestion-related infections (giardiasis, brucellosis). Expatriates returning from all three regions
had higher PM for latent TB, amebiasis, and gastrointestinal infections (other than acute diarrhea) compared to
non-expatriates. When the data were stratified by travel reason, business expatriates had higher PM for febrile
systemic illness (malaria and dengue) and vaccine-preventable infections (hepatitis A), and volunteer expatriates
had higher PM for parasitic infections. Expatriates overall had higher adjusted odds ratios for latent TB and lower
odds ratios for acute diarrhea and dermatologic illness.
Conclusions: Ill returned expatriates differ from other travelers in travel characteristics and proportionate morbidity
for specific diseases, based on the region of exposure and travel reason. They are more likely to present with more
serious illness.
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Background
Expatriates are a diverse group who must adapt to their
host culture, who have a longer duration of exposure to
country-related hazards, and who have the opportunity
to modify risks in their immediate environment [1].
With increasing globalization, expatriate travel has
grown substantially, along with an increasing need to
understand the health issues for these travelers. Despite
this, there is as yet no definitive answer to the number
of expatriates worldwide. United Nations statistics in
2005 indicated 32 million expatriates in the 34 countries
of the Organization for Economic Cooperation and
Development (OECD) [2]. Another study estimated 3
million expatriates in the United Arab Emirates alone
[3]. Given all the countries not included in the estimates
above, the total number of expatriates worldwide may
number well over 40–50 million.
Expatriates have been defined by Foyle as those who
take up residence in another country for occupational
purposes, returning to their country of origin when their
assignment is completed [4]. Using local infrastructure
and longer-term residence abroad expose expatriates to
health risks. Expatriates are therefore considered distinct
from tourists, who use commercial lodgings such as
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hotels or hostels, or travelers visiting friends and rela-
tives (VFRs), who stay in local homes as guests.
Expatriates are also distinct from immigrants in their
nonpermanent residence in their destination country,
although many expatriates reside abroad for long periods,
from months to years.
Few systematic studies have examined the full spectrum
of health problems among different expatriate subgroups
and their destinations. We present data on ill returned
expatriates seen after travel at GeoSentinel sites worldwide
to better guide clinicians and organizations responsible
for expatriate health.
Methods
Data collection
The GeoSentinel Surveillance Network consists of specia-
lized travel or tropical medicine clinics on 6 continents
contributing data on travelers seen during or after travel.
Sentinel surveillance data, including demographic and
travel characteristics, are collected by using standard,
anonymous reporting forms, as described [5]. Final diag-
noses were selected from a standardized list of over 500
diagnostic codes, based on the best available reference
diagnostics in the site country. These diagnoses were
grouped into 21 broad syndrome categories. Individual
patients could have more than one final diagnosis.
Definitions
Site clinicians marked a traveler as “expatriate”, according
to the GeoSentinel data entry definition as those living in
a destination country with an independent residence,
using mostly the infrastructure used by local residents of
the same economic class, independent of duration of resi-
dence. “Non-expatriates” were defined as those who were
not marked to be an “expatriate”, including business and
volunteer travelers staying in hostels and hotels. An
expatriate was further classified by their travel reason
(e.g., business, volunteer). Countries of exposure were
categorized into one of 4 regions: Africa, Asia-Pacific,
Latin America, and “Other” (Europe, North America,
Middle East). Five syndromic groupings of diagnoses
were analyzed: acute diarrhea, systemic febrile illness,
other gastrointestinal (GI) disorders, dermatologic,
and respiratory illness. We further categorized individual
diagnostic codes by mode of transmission: vector-borne,
ingestion, respiratory, blood/body fluid/sexual, environ-
mental contact and noninfectious, similar to previous
studies [6]. Data were analyzed for patients evaluated from
18 March 1997 to 31 May 2011. Patients were included
who presented ill to a GeoSentinel clinic after either
expatriate or non-expatriate travel. Immigrants and VFRs
were excluded. Also excluded were those whose reason
for travel was tourism, education, military, or medical
tourism, as none of these records were classified as an
expatriate. Only patients whose reason for travel was busi-
ness or missionary/volunteer/aid work (abbreviated as
volunteer hereafter) were included.
Ethics
The GeoSentinel data-collection protocol was reviewed
by the institutional review board officer at the National
Center for Infectious Diseases at the Centers for Disease
Control and Prevention and classified as public health sur-
veillance and not as human-subjects research requiring
submission to institutional review boards.
Statistical analysis
Demographic and travel characteristics of expatriates
were compared to non-expatriates, as well as for syn-
dromic illness and specific diagnostic groupings. Propor-
tionate morbidity (PM) was expressed as the number of
patients with a specific syndrome or diagnosis per 1,000 ill
returned expatriates and non-expatriates. A sub-analysis
of expatriates based on travel reason (business vs. volun-
teer) was also performed on syndromic illness and specific
diagnostic groupings. Categorical variables were compared
by using the chi-square test and analyzed by using biva-
riate odds ratios and 95% confidence intervals. For select
diagnostic groupings, multivariable logistic regression was
used, adjusting for factors found to be significant in biva-
riate analyses. SAS 9.2 was used in all statistical analyses.
A value of <0.05 was considered statistically significant.
Results
From March 1997 to May 2011, 14,793 business and
volunteer travelers visited GeoSentinel sites after travel
with confirmed or probable travel-related final diagnoses;
2,883 (19.5%) were ill returned expatriates (Figure 1).
Expatriates were more likely than other travelers to be
male, to have longer trip durations, to travel for volunteer
work, and to have sought pre-travel advice (Table 1).
Comparing expatriates with non-expatriates for syn-
dromic groupings of diagnoses, expatriates ill after
travel had lower PM for acute diarrhea and dermato-
logic and respiratory illnesses but higher PM for
other GI disorders (Table 2).
Region of exposure was associated with differences in
proportionate morbidity when comparing expatriates
and non-expatriates after travel (Table 3). For exposure
in Africa, expatriates had significantly higher PM
compared with non-expatriates for infections transmit-
ted by mosquitoes (malaria, filariasis), by environmental
contact (schistosomiasis), and by ingestion (amebiasis,
hepatitis E). For exposure in the Asia-Pacific region,
expatriates had a higher PM than non-expatriates for stron-
gyloidiasis, filariasis, depression, and anxiety/stress. Com-
pared with the African region, malaria in the Asia-Pacific
region was predominantly due to non-falciparum species.
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By contrast, expatriates exposed in Latin America had
higher PM than non-expatriates for infectious mono-
nucleosis and ingestion-related infections (amebiasis,
giardiasis, and brucellosis). Across all three regions
(Africa, Asia-Pacific, and Latin America), expatriates
had higher PM for latent TB and amebiasis.
When expatriates were grouped by travel reason, busi-
ness expatriates had higher PM for certain febrile systemic
illnesses (malaria and dengue), vaccine-preventable
infections (hepatitis A), HIV, and animal bites com-
pared to business non-expatriates (Table 2). In contrast,
volunteer expatriates had higher PM for anxiety/stress, in-
fectious mononucleosis, and parasitic infections (filariasis,
amebiasis, and strongyloidiasis) compared to volunteer
non-expatriates.
After the data were adjusted for sex, age, travel reason,
trip duration, and exposure region, expatriates had higher
adjusted odds ratios than non-expatriates for gastrointes-
tinal disorders other than acute diarrhea, latent TB and
infectious mononucleosis syndrome (IMS) and lower odds
ratios for acute diarrhea and dermatologic illness, as well as
leishmaniasis, giardiasis, and ectoparasites (Figure 2).
Discussion
This analysis compares 2,883 ill returned expatriates
with 11,910 ill non-expatriates to elucidate differences
in travel patterns and illness seen after travel. Our ex-
patriate definition was formulated independent of travel
duration; therefore, there could have been situations
where expatriates returned ill to their country of citi-
zenship after only a short duration of travel. We have
not excluded these cases from analysis because early
repatriation did not alter the fact that they had
resided abroad as expatriates.
Destination remains one of the most important factors
influencing travel-related illness and is a major focus for
both travel medicine and occupational health clinicians.
Our analysis, showing higher PM for both falciparum
and non-falciparum malaria among expatriates exposed
in Africa and the Asia-Pacific region, respectively, should
Figure 1 Flow chart for analysis of expatriate travelers seen in GeoSentinel Clinics, March 1997 – May 2011.
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guide pre-travel advice and post-travel assessment for
these travelers. The highest PM for filariasis and schisto-
somiasis was observed among expatriates exposed in
Africa, indicating the importance of focusing preventive
advice on mosquito-bite precautions and environmental
contact for these expatriates. Asia-bound expatriates, on
the other hand, may need to be advised about reducing
exposure to tuberculosis, non-falciparum malaria, and
strongyloidiasis. Expatriates exposed in Latin America,
with the highest observed PM among all regions for
amebiasis and infectious mononucleosis, may need to be
advised about exposure to these illnesses.
Malaria carried the highest PM of all specific diagno-
ses, underscoring its importance among expatriates
returning with symptomatic illness. This finding was
true both for expatriates returning from Africa and the
Asia-Pacific region. Although our study cannot estimate
malaria risk, this finding is consistent with past studies
that documented high rates of malaria in a wide range of
expatriates, including missionaries, embassy personnel,
urban expatriates, and Peace Corps volunteers in rural
settings [7-10].
Our study does not provide any information about
malaria chemoprophylaxis. Although two-thirds of our
expatriate sample had sought pre-travel advice, com-
pliance with chemoprophylaxis among expatriates is
known to be suboptimal, possibly related to their longer
duration of travel. One study in Zaire showed the use of
malaria prophylaxis in missionaries at risk has ranged
from 19% to 62% [11]. Among expatriate workers in
Zambia and Ghana, only 44% and 11%, respectively,
used chemoprophylaxis [12,13]. Similarly, business trave-
lers with good understanding of malaria risk also failed
to use appropriate personal protection measures when
trip duration increased [14]. Reasons for noncompliance
may include fear of long-term side effects, medication
fatigue, adverse events, conflicting advice, perceived low
risk of malaria, and complacency. Awareness of these
issues will allow travel medicine practitioners to better
prepare at-risk expatriate travelers [15,16].
GI infections, including acute diarrhea, cause signifi-
cant morbidity among returned travelers globally
[1,5,17]. Our study found that expatriates overall had
lower PM for acute diarrhea and bacterial GI disease
than non-expatriates. Returned expatriates had higher
PM for other GI disorders, so GI illness remains an
important source of morbidity for post-travel assessment.
One possible explanation is that with longer exposure,
partial immunity to acute bacterial pathogens may develop
over time. This effect was seen in expatriates living in a
highly endemic environment in Nepal, where a decreasing
linear relationship was found between the odds ratio for
diarrhea and duration of residence in that country [18].
This could also be due to changes in behavior by expa-
triates over the course of time. Another explanation would
be the limitation of our proportionate morbidity metho-
dology; expatriates could have higher rates and risks for
these conditions but lower PM due to yet higher risks for
other conditions.
Few studies distinguish business expatriates as a sub-
group, distinct from missionaries, volunteers or aid wor-
kers. We found business expatriates had higher PM for
vector-borne and vaccine-preventable infections, probably
due to the broader range of occupations and countries of
origin represented in our dataset. In our dataset, a lower
proportion of business expatriates sought pre-travel con-
sultation compared with missionary expatriates (33% vs.
67%). One implication of these findings is the importance
of trying to reach business expatriates with pre-travel con-
sultations, and focusing the encounter on preventing
malaria, dengue and other vector-borne infections, and
vaccine-preventable diseases such as hepatitis A. HIV
Table 1 Characteristics of ill returned travelers seen at
GeoSentinel Clinics, expatriates versus non-expatriates,
March 1997 – May 2011
All
TOTAL Expatriates Non-
expatriates
(N=14,793) (n=2,883) (n=11,910)
Percentage, %
Male * 58 64 56
Age *
<=19 4 6 4
20-64 92 91 93
65+ 4 4 3
Sought pre-travel advice * 60 70 58
Travel reason *
Business 58 41 62
Volunteer 42 59 38
Trip duration *
<1 month 44 11 53
1-6 months 25 20 26
>6 months 18 51 10
Unknown 13 18 11
Exposure region *
Africa 38 39 37
Asia-Pacific 28 23 30
Latin America 19 25 17
Other a 6 7 6
Unknown 9 6 9
Patient type
Inpatient 10 11 10
Outpatient 90 89 90
* χ2 p-value < 0.01, comparing expatriates with non-expatriates.
a Other includes Europe, Middle East, and North America and does not include
unknown region (n=1277).
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Table 2 Comparison of proportionate morbidity per 1,000 ill returned travelers seen at GeoSentinel clinics by
syndrome and diagnostic groupings, A) expatriate versus nonexpatriate; B) business and volunteer expatriates versus
business and volunteer non-expatriates, March 1997 – May 2011
ALL Business travelers Volunteer travelers
Expatriate Non-expatriate p-value
(bivariate)
Expatriate Non-expatriate p-value
(bivariate)
Expatriate Non-expatriate p-value
(bivariate)
PM per 1,000 PM per 1,000 PM per 1,000
Acute Diarrhea 136 233 <0.01 131 231 <0.01 139 236 <0.01
Febrile/Systemic
Illness
195 201 0.46 265 212 <0.01 147 183 <0.01
Dermatologic 88 121 <0.01 103 115 0.22 79 130 <0.01
GI, Other 121 74 <0.01 112 71 <0.01 127 79 <0.01
Respiratory 49 86 <0.01 75 102 <0.01 31 59 <0.01
Vector-borne
Malaria 84 62 <0.01 109 62 <0.01 67 61 0.37
Dengue 21 23 0.44 31 22 0.05 13 25 <0.01
Leishmaniasis 5 5 0.73 2 4 0.42 8 6 0.60
Rickettsiosis 3 4 0.56 6 5 0.64 1 2 0.41
Filariasis 14 4 <0.01 3 2 0.48 21 6 <0.01
Ingestion
Typhoid &
Paratyphoid
4 5 0.83 6 3 0.18 3 6 0.17
Hepatitis A 3 2 0.35 7 3 0.03 0.6 2 0.69
Hepatitis E 3 0.4 <0.01 3 0.5 0.06 4 0.2 <0.01
GI disease
(parasitic)
15 13 0.28 18 11 0.05 14 16 0.64
GI disease
(bacterial)
11 27 <0.01 14 30 <0.01 9 23 <0.01
Amebiasis 32 17 <0.01 19 16 0.32 41 19 <0.01
Giardiasis 26 32 0.10 24 28 0.36 28 39 0.05
Brucellosis 2 0.4 <0.01 0.8 0.5 0.52 4 0.2 <0.01
Respiratory Contact
Influenza 7 17 <0.01 13 23 0.03 3 9 0.01
Latent TB 19 8 <0.01 26 9 <0.01 14 5 <0.01
Active TB 4 2 0.02 6 2 0.03 3 1 0.07
Blood/Body Fluid/Sexual
HIV 7 2 <0.01 13 3 <0.01 2 1 0.27
Hepatitis B 1 1 0.91 0.8 1 1.00 0.6 0 0.27
IMS1 – EBV2/CMV3 16 7 <0.01 8 8 0.89 22 5 <0.01
Environmental Contact
Schistosomiasis 15 9 <0.01 10 5 0.02 19 15 0.26
Strongyloidiasis 14 5 <0.01 7 3 0.03 19 9 <0.01
Ectoparasites 4 9 <0.01 5 7 0.42 4 12 <0.01
Animal Bites 3 3 0.99 6 2 0.03 0.6 4 0.05
Non-infectious
Fracture &
Dislocation
1 0.4 0.20 0.8 0.3 0.33 1 0.7 0.62
Depression 8 3 <0.01 9 2 <0.01 7 5 0.24
Anxiety & Stress 7 3 <0.01 3 4 1.00 10 3 <0.01
Cardiac Disease 2 1 0.04 4 1 0.02 0.6 0.2 0.47
1IMS=infectious mononucleosis, 2EBV=Epstein-Barr virus; 3CMV=Cytomegalovirus.
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Table 3 Proportionate morbidity per 1,000 ill returned travelers seen at GeoSentinel clinics, for syndrome and
diagnostic groupings by region, expatriates versus non-expatriates, March 1997 – May 2011
AFRICA (n=5575) ASIA-PACIFIC (n=4200) LATIN AMERICA (n=2787) OTHER REGIONS¥ (n=954) p-value *
Expatriate Non-
expatriate
Expatriate Non-
expatriate
Expatriate Non-
expatriate
Expatriate Non-
expatriate
PM per 1,000
Syndrome Groupings
Acute Diarrhea 139 226 147 273 129 240 113 171 a,b,c
Febrile/Systemic
Illness
289 263 195 203 95 148 77 103 c
Dermatologic 73 111 94 111 103 179 93 122 a,c
GI, Other 101 65 140 68 136 70 124 86 a,b,c
Respiratory 45 67 68 104 23 58 88 186 a,b,c,d
Diagnostic Groupings
Vector-borne
Malaria 178 121 51 43 7 16 0 3 a
P.falciparum 115 86 9 13 1 4 0 0 a
Malaria, other £ 56 30 40 31 4 12 0 3 a
Dengue 6 7 52 46 20 36 0 0
Leishmaniasis 3 3 2 1 15 15 0 12
Rickettsiosis 4 8 5 1 0 2 0 1
Filariasis 31 7 6 1 3 3 0 1 a,b
Ingestion
Typhoid &
Paratyphoid
4 3 10 10 1 3 0 0
Hepatitis A 3 2 6 2 1 1 5 4
Hepatitis E 5 0.2 3 1 1 0 0 0 a
GI (parasitic) 14 8 21 13 14 23 10 8
GI (bacterial) 9 27 13 39 12 18 5 29 a,b
Amebiasis 31 16 30 16 42 22 21 17 a,b,c
Giardiasis 33 32 30 37 14 30 10 21 c
Brucellosis 2 0.2 2 1 4 0 5 3 c
Respiratory Contact
Influenza 6 14 9 22 3 7 21 45 b
Latent TB 13 4 25 7 15 5 36 21 a,b,c
Active TB 3 1 3 2 5 2 10 4
Blood/Body Fluid/Sexual
HIV 5 2 5 2 3 3 41 5 d
Hepatitis B 2 0 0 1 0 0 0 1
IMS – EBV/CMV 5 5 15 9 34 8 26 9 c
Environmental Contact
Schistosomiasis 36 19 1 2 1 2 5 5 a
Strongyloidiasis 13 6 16 3 15 6 10 3 b
Ectoparasites 5 10 0 4 7 20 0 7 c
Animal Bites 2 3 7 4 0 3 5 3
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infection and animal bites may also represent important
but sometimes neglected topics for preventive advice and
vaccination among business expatriates. However, these
findings are based on low numbers, so the data should be
interpreted with caution.
Volunteer expatriates were observed to have higher
PM for parasitic infections, possibly reflecting greater
rural exposure. Guidance for these travelers may need to
focus on preventing parasites transmitted via mosquitoes
(filariasis), ingestion (amebiasis), and environmental
contact (schistosomiasis, strongyloidiasis), as well as
anxiety/stress issues. Compared with non-expatriates,
stressors experienced by expatriates may include a
greater need to adapt to the culture, language, or infra-
structure of the host country, loss of usual social
supports, or work problems. Estimates of mental health
problems range from 4% of health events in Peace Corps
volunteers [19] to 10% in a study of British missionaries
in 27 countries [8], with depression reported as the most
common reason for psychiatric assessment [20]. Volun-
teer expatriates, such as aid workers or missionaries,
may experience more psychological stressors. A retro-
spective study of 1250 returned Red Cross expatriates
reported that 40% found their mission more stressful
than expected, and 16% were exposed to at least one act
of violence [21].
Although we excluded patients seen only for screening
visits, we observed higher PM for latent TB among
expatriates than non-expatriates, even after adjustment
for age, sex, travel reason, travel duration, and region of
exposure. Some of this difference may be due to screen-
ing protocols in different organizations. The higher PM
for active TB among expatriates suggests these travelers
may indeed have more exposure to TB. This finding is
consistent with other studies which showed US Peace
Corps volunteers with purified protein derivative (PPD)
conversion rates of 1.3 per 1,000 volunteer-months [22],
probably reflecting a true increased exposure to TB in
higher-incidence regions.
Several negative findings in this analysis are worth
noting. Enteric fever (typhoid/paratyphoid) is the most
common bacteremic disease affecting travelers to the
tropics [23], but in our study, we did not find any signifi-
cantly different PM for enteric fever among expatriates
as compared to non-expatriates. We found no cases of
Japanese encephalitis, cholera, or meningococcal disease
among the 14,793 ill returned expatriates and non-
expatriates. Because these are rare diseases, our analysis
may lack sufficient power to detect very low-incidence
illnesses, which is a potential limitation of this study.
Our analysis using GeoSentinel data has several other
important general limitations. First, the data do not rep-
resent a comprehensive epidemiologic analysis, with uni-
form and comprehensive sampling of all travel-related
illnesses. Therefore, more severe or complex diseases
may be overrepresented because of referrals to specia-
lized GeoSentinel clinics, along with an underrepresenta-
tion of mild or self-limited conditions normally seen at
nonspecialized primary care practices. Furthermore,
diseases with short incubation periods with onset during
the trip abroad (such as acute diarrhea) would also be
underrepresented because the sample contains data only
for post-travel patients. Second, because a comparison
group of healthy travelers is unavailable, rates and risks
could not be calculated for travel-related illness in
expatriates and non-expatriates. Our odds ratio results
should be interpreted accordingly. Last, high proportions
of missing values were found for region of exposure and
trip duration (9% and 10%, respectively); however, com-
parisons of missing to non-missing produced no statistical
differences for demographic variables such as sex and
age; these comparisons were included in the adjusted
multivariate logistic regression.
After adjusting for demographics, travel reason, trip
duration or region of exposure, our results indicate that
expatriate travel did not have increased odds for some of
the illnesses we are concerned about such as malaria.
Malaria is seen commonly among expatriates but this may
be due to longer duration of travel or region of exposure
rather than the expatriate nature of travel. However,
expatriates seen after travel do have increased adjusted
odds for GI diseases other than acute diarrhea, and latent
TB infection. The reliance of expatriates on local infra-
structure, broader contact with endemic populations or
Table 3 Proportionate morbidity per 1,000 ill returned travelers seen at GeoSentinel clinics, for syndrome and
diagnostic groupings by region, expatriates versus non-expatriates, March 1997 – May 2011 (Continued)
Non-infectious
Fracture & Dislocation 0 0.4 2 1 0 1 10 0 d
Depression 3 3 12 2 8 3 16 7 b
Anxiety & Stress 8 4 7 1 4 3 21 5 b
Cardiac Disease 3 0.4 2 0.6 0 1 0 1
* Comparing expatriate to non-expatriate, if p-value < 0.01, denoted a for Africa, b - Asia-Pacific, c - Latin America, d - Other.
¥ Other regions include Europe, Middle East, and North America and does not include unknown region (n=1277).
£ Malaria, other includes species unknown, P. vivax, P. malariae, P. ovale, P.v., and mefloquine-resistant.
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Figure 2 Adjusted odds ratios by major syndrome groupings and selected diagnostic groupings of ill returned travelers seen at
GeoSentinel clinics, expatriates vs. non-expatriates, March 1997 – May 2011 * Adjusted for sex, age, travel reason, trip duration, and
exposure region.
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behavior adaptations may increase expatriate exposure to
these diseases. Understanding these results as well as the
limitations of our data will further elucidate the role of
expatriate travel and the factors that impact clinical out-
comes in expatriates returning with symptomatic illness.
We hope these insights will serve to inform the practice of
clinicians and organizations serving expatriates, both in
pre-travel preparation and post-travel consultations.
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